Ciborowski Burgess Medical Limited 13989261 false 2022-03-19 2023-03-31 2023-03-31 The principal activity of the company is Specialists medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 13989261 2022-03-19 2023-03-31 13989261 2023-03-31 13989261 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 13989261 bus:Micro-entities 2022-03-19 2023-03-31 13989261 bus:AuditExemptWithAccountantsReport 2022-03-19 2023-03-31 13989261 bus:FullAccounts 2022-03-19 2023-03-31 13989261 bus:SmallCompaniesRegimeForAccounts 2022-03-19 2023-03-31 13989261 bus:RegisteredOffice 2022-03-19 2023-03-31 13989261 bus:Director1 2022-03-19 2023-03-31 13989261 bus:PrivateLimitedCompanyLtd 2022-03-19 2023-03-31 13989261 bus:Agent1 2022-03-19 2023-03-31 13989261 countries:EnglandWales 2022-03-19 2023-03-31 iso4217:GBP xbrli:pure

Ciborowski Burgess Medical Limited

trading as Ciborowski Burgess Medical Limited

Registration number : 13989261



















Annual Report and Unaudited Financial Statements

for the period from 19 March 2022 to 31 March 2023

 

Ciborowski Burgess Medical Limited

trading as Ciborowski Burgess Medical Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3

Notes to the Unaudited Financial Statements

4

 

Ciborowski Burgess Medical Limited

trading as Ciborowski Burgess Medical Limited

Company Information

Director

Dr Jennifer Lynne Burgess

Registered office

Maghull Business Centre
1 Liverpool Road North
Maghull
Merseyside
L31 2HB

Accountants

McParland Williams Limited
13 Liverpool Road North
Maghull
Merseyside
L31 2HB

 

Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of Ciborowski Burgess Medical Limited

trading as Ciborowski Burgess Medical Limited
for the period ended 31 March 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Ciborowski Burgess Medical Limited for the period ended 31 March 2023 as set out on pages 3 to 4 from the company's accounting records and from information and explanations you have given us.

This report is made solely to the Board of Directors of Ciborowski Burgess Medical Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Ciborowski Burgess Medical Limited and state those matters that we have agreed to state to the Board of Directors of Ciborowski Burgess Medical Limited. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Ciborowski Burgess Medical Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Ciborowski Burgess Medical Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Ciborowski Burgess Medical Limited. You consider that Ciborowski Burgess Medical Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the accounts of Ciborowski Burgess Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

image-name

McParland Williams Limited
13 Liverpool Road North
Maghull
Merseyside
L31 2HB

5 September 2023

 

Ciborowski Burgess Medical Limited

trading as Ciborowski Burgess Medical Limited

(Registration number: 13989261)
Balance Sheet as at 31 March 2023

2023
£

Current assets

20,781

Creditors: Amounts falling due within one year

(5,656)

 

15,125

Capital and reserves

15,125

For the financial period ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the director on 5 September 2023
 

.........................................
Dr Jennifer Lynne Burgess
Director

   
     
 

Ciborowski Burgess Medical Limited

trading as Ciborowski Burgess Medical Limited

Notes to the Unaudited Financial Statements for the period from 19 March 2022 to 31 March 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Maghull Business Centre
1 Liverpool Road North
Maghull
Merseyside
L31 2HB

These financial statements were authorised for issue by the director on 5 September 2023.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.